KALVISTA PHARMACEUTICALS INC. news, videos and press releases - Page 4
For more news please use our advanced search feature.
KALVISTA PHARMACEUTICALS INC. - More news...
KALVISTA PHARMACEUTICALS INC. - More news...
- KalVista Pharmaceuticals to Present at SVB Leerink Global Healthcare Conference
- KalVista Pharmaceuticals Announces the Closing of its Upsized Public Offering of Common Stock and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
- KalVista Pharmaceuticals Announces Pricing of an Upsized $193.5 Million Public Offering of Common Stock
- KalVista Pharmaceuticals Announces Proposed Public Offering of Common Stock
-
KalVista Pharmaceuticals, Inc. - KALV Stock Chart Technical Analysis for 02-09-2021
- KalVista Pharmaceuticals Reports Positive Results for KVD900 Phase 2 Demonstrating Statistically and Clinically Significant Responses Across All Endpoints as an Oral On-Demand Treatment for HAE Attacks
- KalVista Pharmaceuticals Reports Second Fiscal Quarter Results
- KalVista Pharmaceuticals to Present at Upcoming Investor Conferences
- KalVista Pharmaceuticals Provides Update on Oral Hereditary Angioedema Franchise
- KalVista Pharmaceuticals Reports First Fiscal Quarter Results
- KalVista Pharmaceuticals to Present at Cantor Global Healthcare Conference
- KalVista Pharmaceuticals to Present at BTIG Virtual Biotechnology Conference
- KalVista Pharmaceuticals Provides Operational Update and Fiscal Year Financial Results
- KalVista Pharmaceuticals to Present at Jefferies Virtual Healthcare Conference
- KalVista Pharmaceuticals to Present at 19th Annual Needham Healthcare Conference
- KalVista Pharmaceuticals Provides Operational and Financial Update
- KalVista Pharmaceuticals Reports Fiscal Third Quarter Results
- KalVista Pharmaceuticals to Present at SVB Leerink 9th Annual Global Healthcare Conference
- KalVista Pharmaceuticals Provides Update on Diabetic Macular Edema Programs
- KalVista Pharmaceuticals Provides Update on Oral Hereditary Angioedema Franchise
- KalVista Pharmaceuticals Reports Phase 2 Clinical Trial Results in Patients with Diabetic Macular Edema
- KalVista Pharmaceuticals Reports Fiscal Second Quarter Results
- KalVista Pharmaceuticals to Present at Cantor Global Healthcare Conference
- KalVista Pharmaceuticals Reports Fiscal First Quarter Results
- KalVista Pharmaceuticals Provides Operational Update and Reports Fiscal Fourth Quarter and Full Year Financial Results
- KalVista Pharmaceuticals to Present at Jefferies Healthcare Conference
- KalVista Pharmaceuticals to Recognize HAE Day 2017
- KalVista Pharmaceuticals Reports Fiscal Third Quarter Results
- KalVista Pharmaceuticals Appoints Dr. Andreas Maetzel Senior Vice President of Medical
-
KalVista Pharmaceuticals
